88 related articles for article (PubMed ID: 11586939)
1. Psoriasis: new drugs on the horizon?
Bonney RC
Am Clin Lab; 2001 Sep; 20(8):30-1. PubMed ID: 11586939
[No Abstract] [Full Text] [Related]
2. The Immunogenetics of Psoriasis and Implications for Drug Repositioning.
Xu X; Zhang HY
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292715
[TBL] [Abstract][Full Text] [Related]
3. Patented small molecules against psoriasis.
Abdelnoor AM
Expert Opin Ther Pat; 2009 Aug; 19(8):1057-71. PubMed ID: 19566378
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.
Ghoreschi K; Thomas P; Breit S; Dugas M; Mailhammer R; van Eden W; van der Zee R; Biedermann T; Prinz J; Mack M; Mrowietz U; Christophers E; Schlöndorff D; Plewig G; Sander CA; Röcken M
Nat Med; 2003 Jan; 9(1):40-6. PubMed ID: 12461524
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis: a fresh look.
Galadari I; Sharif MO; Galadari H
Clin Dermatol; 2005; 23(5):491-502. PubMed ID: 16179183
[TBL] [Abstract][Full Text] [Related]
6. The 'heartbreak of psoriasis' has met its match!
Morrow T
Manag Care; 2003 Jun; 12(6):13, 17-8. PubMed ID: 12854254
[No Abstract] [Full Text] [Related]
7. Potential new insight into the pathogenesis of psoriasis.
Woodley DT; Kim GH
Arch Dermatol; 2009 Jun; 145(6):713-4. PubMed ID: 19528431
[No Abstract] [Full Text] [Related]
8. Spondyloarthropathy: disease at the crossroads of immunity.
FitzGerald O; McInnes I
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):949-67. PubMed ID: 16980217
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
Piskin G; Heydendael VM; de Rie MA; Bos JD; Teunissen MB
Arch Dermatol Res; 2003 Mar; 294(12):559-62. PubMed ID: 12624782
[No Abstract] [Full Text] [Related]
10. Immunopathogenesis and role of T cells in psoriasis.
Ghoreschi K; Weigert C; Röcken M
Clin Dermatol; 2007; 25(6):574-80. PubMed ID: 18021895
[TBL] [Abstract][Full Text] [Related]
11. Immunopathogenesis of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2006 Aug; 47(3):151-9. PubMed ID: 16866993
[TBL] [Abstract][Full Text] [Related]
12. Targeting interleukin-2 as a treatment for psoriasis.
Salim A; Emerson R
Curr Opin Investig Drugs; 2001 Nov; 2(11):1546-8. PubMed ID: 11763155
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of psoriasis: basic principles and new options].
Vereecken P; Provost P; Willaert F; Heenen M; Bentin J
Rev Med Brux; 2007 Sep; 28(4):336-44. PubMed ID: 17958030
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
[TBL] [Abstract][Full Text] [Related]
15. Disease mimicry--a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry?
Prinz JC
Autoimmun Rev; 2004 Jan; 3(1):10-5. PubMed ID: 14871644
[TBL] [Abstract][Full Text] [Related]
16. [Interleukin-4: a new option in the therapy of systemic psoriasis?].
Homey B
Hautarzt; 2003 Oct; 54(10):1019-20. PubMed ID: 14577420
[No Abstract] [Full Text] [Related]
17. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression.
Lew W; Bowcock AM; Krueger JG
Trends Immunol; 2004 Jun; 25(6):295-305. PubMed ID: 15145319
[No Abstract] [Full Text] [Related]
18. Pathogenesis and therapy of psoriasis.
Lowes MA; Bowcock AM; Krueger JG
Nature; 2007 Feb; 445(7130):866-73. PubMed ID: 17314973
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis pathophysiology: current concepts of pathogenesis.
Krueger JG; Bowcock A
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii30-6. PubMed ID: 15708932
[TBL] [Abstract][Full Text] [Related]
20. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
Bovenschen HJ; Van De Kerkhof PC; Gerritsen WJ; Seyger MM
Eur J Dermatol; 2005; 15(6):454-8. PubMed ID: 16280298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
